These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 8406594

  • 1. Characterization of a monoclonal antibody to cis-urocanic acid: detection of cis-urocanic acid in the serum of irradiated mice by immunoassay.
    Moodycliffe AM, Norval M, Kimber I, Simpson TJ.
    Immunology; 1993 Aug; 79(4):667-72. PubMed ID: 8406594
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation.
    Moodycliffe AM, Bucana CD, Kripke ML, Norval M, Ullrich SE.
    J Immunol; 1996 Oct 01; 157(7):2891-9. PubMed ID: 8816394
    [Abstract] [Full Text] [Related]

  • 3. The role of cis-urocanic acid in UVB-induced suppression of contact hypersensitivity.
    Kondo S, Sauder DN, McKenzie RC, Fujisawa H, Shivji GM, El-Ghorr A, Norval M.
    Immunol Lett; 1995 Dec 01; 48(3):181-6. PubMed ID: 8867849
    [Abstract] [Full Text] [Related]

  • 4. Quantification of urocanic acid isomers in murine skin during development and after irradiation with UVB light.
    Norval M, McIntyre CR, Simpson TJ, Howie SE, Bardshiri E.
    Photodermatol; 1988 Aug 01; 5(4):179-86. PubMed ID: 2852797
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Suppression of contact hypersensitivity by short-term ultraviolet irradiation: II. The role of urocanic acid.
    Harriott-Smith TG, Halliday WJ.
    Clin Exp Immunol; 1988 Apr 01; 72(1):174-7. PubMed ID: 3396218
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regulation of tumor antigen presentation by urocanic acid.
    Beissert S, Mohammad T, Torri H, Lonati A, Yan Z, Morrison H, Granstein RD.
    J Immunol; 1997 Jul 01; 159(1):92-6. PubMed ID: 9200443
    [Abstract] [Full Text] [Related]

  • 9. The effect of histamine receptor antagonists on immunosuppression induced by the cis-isomer of urocanic acid.
    Norval M, Gilmour JW, Simpson TJ.
    Photodermatol Photoimmunol Photomed; 1990 Dec 01; 7(6):243-8. PubMed ID: 1983293
    [Abstract] [Full Text] [Related]

  • 10. Urocanic acid and cutaneous antigen presentation.
    Lappin MB, Simon JC.
    J Photochem Photobiol B; 1998 Jul 10; 44(2):112-6. PubMed ID: 9757592
    [Abstract] [Full Text] [Related]

  • 11. The effect of ultraviolet B irradiation, cis-urocanic acid and tumour necrosis factor-alpha on delayed hypersensitivity to herpes simplex virus.
    Gilmour JW, Norval M.
    Photodermatol Photoimmunol Photomed; 1998 Jul 10; 9(6):255-61. PubMed ID: 1343227
    [Abstract] [Full Text] [Related]

  • 12. The degradation of L-histidine and trans- and cis-urocanic acid by bacteria from skin and the role of bacterial cis-urocanic acid isomerase.
    Hug DH, Dunkerson DD, Hunter JK.
    J Photochem Photobiol B; 1999 May 10; 50(1):66-73. PubMed ID: 10443033
    [Abstract] [Full Text] [Related]

  • 13. Stereospecific inhibition of human epidermal cell interleukin-1 secretion and HLA-DR expression by cis-urocanic acid.
    Räsänen L, Jansén CT, Reunala T, Morrison H.
    Photodermatol; 1987 Aug 10; 4(4):182-6. PubMed ID: 3501579
    [Abstract] [Full Text] [Related]

  • 14. The role of urocanic acid in UVB-induced suppression of immunity to Trichinella spiralis infection in the rat.
    Garssen J, Norval M, Crosby J, Dortant P, Van Loveren H.
    Immunology; 1999 Feb 10; 96(2):298-306. PubMed ID: 10233709
    [Abstract] [Full Text] [Related]

  • 15. cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha.
    Kurimoto I, Streilein JW.
    J Immunol; 1992 May 15; 148(10):3072-8. PubMed ID: 1578133
    [Abstract] [Full Text] [Related]

  • 16. Cis-urocanic acid, a product formed by ultraviolet B irradiation of the skin, initiates an antigen presentation defect in splenic dendritic cells in vivo.
    Noonan FP, De Fabo EC, Morrison H.
    J Invest Dermatol; 1988 Feb 15; 90(2):92-9. PubMed ID: 2448393
    [Abstract] [Full Text] [Related]

  • 17. Suppression of different phases of systemic contact hypersensitivity by urocanic acid oxidation products.
    Kammeyer A, Garssen J, Sleijffers A, van Loveren H, Eggelte TA, Bos JD, Teunissen MB.
    Photochem Photobiol; 2004 Feb 15; 80():72-7. PubMed ID: 15339212
    [Abstract] [Full Text] [Related]

  • 18. Screening of urocanic acid isomers in human basal and squamous cell carcinoma tumors compared with tumor periphery and healthy skin.
    Decara JM, Aguilera J, Abdala R, Sánchez P, Figueroa FL, Herrera E.
    Exp Dermatol; 2008 Oct 15; 17(10):806-12. PubMed ID: 18312386
    [Abstract] [Full Text] [Related]

  • 19. The evaluation of the amount of cis- and trans-urocanic acid in the stratum corneum by Raman spectroscopy.
    Egawa M, Nomura J, Iwaki H.
    Photochem Photobiol Sci; 2010 May 15; 9(5):730-3. PubMed ID: 20442934
    [Abstract] [Full Text] [Related]

  • 20. A critical role for dermal mast cells in cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses in mice.
    Hart PH, Grimbaldeston MA, Swift GJ, Hosszu EK, Finlay-Jones JJ.
    Photochem Photobiol; 1999 Nov 15; 70(5):807-12. PubMed ID: 10568173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.